STAMBP-IN-1

• CAT Number: I042654
• CAS Number: 896683-78-6
• Molecular Formula: C27H28N4O4S
• Molecular Weight: 504.60
• Purity: ≥95%
• Synonyms: N-(furan-2-ylmethyl)-2-[6-morpholin-4-yl-4-oxo-3-(2-phenylethyl)quinazolin-2-yl]sulfanylacetamide
• InChI: InChI=1S/C27H28N4O4S/c32-25(28-18-22-7-4-14-35-22)19-36-27-29-24-9-8-21(30-12-15-34-16-13-30)17-23(24)26(33)31(27)11-10-20-5-2-1-3-6-20/h1-9,14,17H,10-13,15-16,18-19H2,(H,28,32)
• InChIKey: HBAWGWWMULJGHR-UHFFFAOYSA-N
• SMILES: C1COCCN1C2=CC3=C(C=C2)N=C(N(C3=O)CCC4=CC=CC=C4)SCC(=O)NCC5=CC=CO5

STAMBP-IN-1（Cat No.:I042654）is a selective inhibitor of STAMBP (Signal Transducing Adaptor Molecule Binding Protein), a protein that plays a crucial role in the regulation of endosomal trafficking and receptor signaling. By inhibiting STAMBP, this compound interferes with the protein’s involvement in cellular processes like immune response, protein degradation, and cell signaling. STAMBP-IN-1 is being studied for its potential therapeutic applications in diseases where STAMBP-mediated signaling is dysregulated, such as cancers and inflammatory conditions. Its ability to modulate these pathways makes it a promising candidate for drug development in targeted therapies.